InvestSMART

Saluda Medical, Inc. (ASX: SLD) - Announcements

- Current share price for SLD : $0.410

ASX company news and announcements for Saluda Medical, Inc. (SLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Saluda Medical, Inc. (SLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Saluda Medical, Inc. (SLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Saluda Medical, Inc. (SLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$103 CEO Transition 7 Sep 2026 11:43AM $0.420 $0.410 fallen by 2.38%
$103 S&P DJI Announces September 2026 Quarterly Rebalance 4 Sep 2026 5:10PM $0.430 $0.410 fallen by 4.65%
$103 Change in substantial holding 28 Aug 2026 4:28PM $0.480 $0.410 fallen by 14.58%
$103 FY26 Results Presentation 28 Aug 2026 8:26AM $0.635 $0.410 fallen by 35.43%
$103 FY26 Full Year Results 28 Aug 2026 8:24AM $0.635 $0.410 fallen by 35.43%
$103 Preliminary Final Report 28 Aug 2026 8:21AM $0.635 $0.410 fallen by 35.43%
$103 FY26 Results & Webinar, 2026 AGM Notification 18 Aug 2026 12:55PM $0.605 $0.410 fallen by 32.23%
$103 Quarterly Investor Presentation 29 Jul 2026 8:31AM $0.410 $0.410 fallen by 0%
$103 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2026 8:31AM $0.410 $0.410 fallen by 0%
$103 First U.S. Surgical Cases Using CAP24 Paddle Leads 16 Jul 2026 10:48AM $0.535 $0.410 fallen by 23.36%
$103 Change in substantial holding 13 Jul 2026 1:39PM $0.500 $0.410 fallen by 18%
$103 Notification of cessation of securities - SLD 13 Jul 2026 8:32AM $0.520 $0.410 fallen by 21.15%
$103 Notification regarding unquoted securities - SLD 13 Jul 2026 8:32AM $0.520 $0.410 fallen by 21.15%
$103 Notification regarding unquoted securities - SLD 1 Jul 2026 9:57AM $0.460 $0.410 fallen by 10.87%
$103 SLD Draws US$25m Second Tranche of Credit Facility 1 Jul 2026 9:32AM $0.460 $0.410 fallen by 10.87%
$103 SLD Receives FDA Approval for CAP24 Surgical Paddle Lead 30 Jun 2026 9:29AM $0.410 $0.410 fallen by 0%
$103 ASIC Approval of Financial Reporting Relief for Subsidiary 15 May 2026 10:33AM $0.493 $0.410 fallen by 16.75%
$103 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 8:17AM $0.590 $0.410 fallen by 30.51%
$103 Notification of cessation of securities - SLD 10 Apr 2026 8:25AM $0.790 $0.410 fallen by 48.10%
$103 Notification regarding unquoted securities - SLD 10 Apr 2026 8:25AM $0.790 $0.410 fallen by 48.10%
$103 Update - S&P DJI March 2026 Rebalance of the All Ordinaries 10 Mar 2026 5:28PM $1.015 $0.410 fallen by 59.61%
$103 S&P DJI Announces March 2026 Quarterly Rebalance 6 Mar 2026 5:05PM $0.970 $0.410 fallen by 57.73%
$103 H1 FY2026 Results Announcement 26 Feb 2026 9:24AM $0.990 $0.410 fallen by 58.59%
$103 Half Yearly Report and Accounts 26 Feb 2026 9:21AM $0.990 $0.410 fallen by 58.59%
$103 H1 FY26 Results Notification & Webinar 17 Feb 2026 10:46AM $0.990 $0.410 fallen by 58.59%

1 - 25 of 90 results

Page 1 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.